FDA Enforcement Report Find 274 patient testimonials about Spironolactone and 154 patient testimonials about Aldactone at Ask a Patient Drug Recall: Compounded Semaglutide and Tirzepatide Aequita Pharmacy, a licensed compounding pharmacy in Kirkland, Washington, is recalling over 2,000 multi-dose vials of injectable GLP-1 semaglutide and tirzepatide products because of a lack of processing controls. Lack of oversight in the compounding facility could impact medication sterility, dosage accuracy, and stability
Supporting natural metabolic function This is where microdosing creates an opportunity
The condition is caused by decreased blood supply to the optic nerve and may cause sudden, irreversible vision loss
However, for people with diabetes and gum diseasewhich often go together, due in part to elevated glucose in salivaGLP-1s might be helpful, suggests research published in the Journal of Periodontal Research
FDA Approval The U.S
Aliquoting Strategy For research programs that need tirzepatide solution at multiple timepoints over weeks or months, aliquoting is the correct approach: Reconstitute the lyophilized stock into a working solution
